{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"36.7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}],"units":"Participants"}],"description":"Outcome measure was the total of daytime napping minutes in a week as assessed by participant sleep diaries","dispersionType":"Standard Deviation","groups":[{"description":"Patients receive oral methylphenidate extended-release once daily for 7-42 days in the absence of unacceptable toxicity.","id":"OG000","title":"Arm I - Methylphenidate Hydrochloride"},{"description":"Patients receive oral modafinil once daily for 7-42 days in the absence of unacceptable toxicity.","id":"OG001","title":"Arm II -Modafinil"},{"description":"Patients receive oral placebo once daily for 7-42 days in the absence of unacceptable toxicity.","id":"OG002","title":"Arm III Placebo"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"29 days","title":"Average Daytime Napping Minutes in a Week","type":"PRIMARY","unitOfMeasure":"minutes"}